A carregar...

Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1

PURPOSE: The narrow therapeutic index and large interpatient variability in sirolimus pharmacokinetics (PK) make therapeutic drug monitoring necessary. Factors responsible for PK variability are not well understood, and published PK studies do not include pediatric patients with neurofibromatosis ty...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scott, Jeffrey R., Courter, Joshua D., Saldaña, Shannon N., Widemann, Brigitte C., Fisher, Michael, Weiss, Brian, Perentesis, John, Vinks, Alexander A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3660960/
https://ncbi.nlm.nih.gov/pubmed/23666574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0b013e318286dd3f
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!